American Specialty Health, which has two offices in San Diego, announced Sept. 11 that it filed a trademark counterfeiting and infringement lawsuit against Modesto-based American Specialty Healthcare and American Specialty College, along with a number of its executives.
San Diego medical device and spine surgery company NuVasive on Sept. 7 announced that it acquired Vertera Spine, a privately-held medical device company that develops implants for spinal fusion.
Local biotech Zavante Therapeutics is teaming up with the National Institutes of Health to see if its antibiotic will fight nasty infections acquired in hospitals.
Global pharmaceutical giant Allergan is suing small San Diego drugmaker Imprimis Pharmaceuticals, claiming the local company is illegally selling unapproved new drugs.
San Diego’s Dexcom and Fitbit announced a partnership to develop and market products that aim to help people better manage diabetes and overall health.
Local drugmaker MEI Pharma has agreed to pay $2.9 million upfront to Presage Biosciences for exclusive global rights to a potential new drug.
Ardea Biosciences, the local biotech now owned by AstraZeneca, got the green light from regulators to sell a new drug developed in San Diego labs. It’s the second medicine to make it from Ardea’s labs to the market, and will likely be the last.
Vividion Therapeutics, a biotech startup that received $50 million in backing earlier this year, just recruited a top biotech executive as CEO and appointed industry heavyweight Rich Heyman to its board.
Susan G. Komen San Diego, the county’s largest funder of breast health services, has tapped Shaina Gross as the nonprofit’s new president and CEO.
NuVasive announced on Wednesday that it won FDA 510(k) clearance for its spinal implant system to treat early onset scoliosis.
Faheem Hasnain, a well-respected biotech executive in San Diego, has been appointed chairman of Vital Therapies Inc.’s Board of Directors.
San Diego’s DNA intelligence company Human Longevity has developed an algorithm that can predict what people look like using only their genome sequence.
In a move announced Sept. 5, Jason Hannon, until recently NuVasive’s president and COO, will take the reins as the CEO of Mainstay Medical International, a medical device company.
The California Department of Public Health on Thursday issued fines totaling $233,650 for three San Diego hospitals after investigations that found severe patient safety violations.
Three local life science companies reported incoming cash during August, although none announced the deals publicly.